October 7, 2024 Via Email and DocuSign Dong (Don) Kim don.kim@urogen.com Dear Don:UroGen Pharma Ltd. • October 9th, 2024 • Pharmaceutical preparations
This letter sets forth the substance of the separation and consulting agreement (the “Agreement”) that UroGen Pharma, Inc. (the “Subsidiary”), a wholly owned subsidiary of UroGen Pharma Ltd. (the “Parent” and together with the Subsidiary, the “Company”) is offering to you to aid in your employment transition.
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • October 9th, 2024 • UroGen Pharma Ltd. • Pharmaceutical preparations • New Jersey
This Executive Employment Agreement (the “Agreement”), is hereby made this 7th day of October, 2024, between UroGen Pharma, Inc., a wholly owned subsidiary (the “Subsidiary”) of UroGen Pharma Ltd. (the “Parent”, and the Subsidiary and the Parent together, the “Company”), and Chris Degnan (the “Executive”) (collectively, the “Parties”).
